Filing Flows › Biodesix (BDSX) › Guidance history
Biodesix (BDSX) guidance history: what it guided and what it reported
Biodesix gave guidance in 3 earnings releases on file since May 4, 2026. Its releases raised guidance once and lowered it once.
Revenue
Every guided period is still to be reported.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $108M–$114M (May 4, 2026) → reaffirmed $108M–$114M (Aug 5, 2026) → lowered $101M–$103M (Nov 5, 2026) | — | to be reported | — |
Gross margin
Every guided period is still to be reported.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | 80.0% (May 4, 2026) → reaffirmed 80.0% (Aug 5, 2026) → reaffirmed 80.0% (Nov 5, 2026) | — | to be reported | — |
The latest quarter
Biodesix, Q3 2026: revenue $24.0M (+10% year over year), operating margin -25.4%, net loss $8.0M, operating cash flow −$7.2M. The chart follows the revenue to costs, profit and cash.
Questions
Does Biodesix beat its guidance?
Biodesix gave guidance in 3 earnings releases on file since May 4, 2026. Its releases raised guidance once and lowered it once.
How often does Biodesix raise guidance?
Its earnings releases raised guidance once and lowered it once since May 4, 2026.
Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.